County
Dorchester County EMS
Dorchester County EMS (SC) carries 39 drugs across 154 dose entries in its current published protocol, effective 2025-11-01.
Drugs and doses39
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg | PO | not captured | standing | page 123 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 123 |
| Fever | peds | 60–120 mg | PR | not captured | standing | page 123 |
| Mild to moderate pain | adult | 1000 mg | PO | not captured | standing | page 34 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 34 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 169 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 169 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 12 mg | IV/IO | not captured | standing | page 54 |
| Atrial fibrillation with RVR | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 54 |
| SVT | adult | 12 mg | IV/IO | not captured | standing | page 54 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 54 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 2.5 mg | NEB | not captured | standing | page 68 |
| Crush injury | peds | 2.5 mg | NEB | not captured | standing | page 68 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | page 97 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | page 97 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | page 36 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | page 36 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 66 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 66 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 64 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 64 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 66 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 66 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 56 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 56 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 154 |
| Cardiac arrest | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 154 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 100 mg/kg | IV/IO | not captured | standing | page 125 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 100 mg/kg | IV/IO | not captured | standing | page 125 |
| Cardiac arrest | adult | 100 mg/kg | IV/IO | not captured | standing | page 28 |
| Cardiac arrest | peds | 100 mg/kg | IV/IO | not captured | standing | page 28 |
| Crush injury | adult | 100 mg/kg | IV/IO | not captured | standing | page 68 |
| Crush injury | peds | 60 mg/kg | IV/IO | not captured | standing | page 68 |
| Hyperkalemia | adult | 100 mg/kg | IV/IO | not captured | standing | page 28 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | page 28 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | page 72 |
| Other | adult | 1 g | IV | not captured | standing | page 72 |
| Other | peds | 30 mg/kg | IV | not captured | standing | page 72 |
| Other | peds | 30 mg/kg | IV | not captured | standing | page 72 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 72 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 72 |
| Trauma / hemorrhage | peds | 30 mg/kg | IV | not captured | standing | page 72 |
| Trauma / hemorrhage | peds | 30 mg/kg | IV | not captured | standing | page 72 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IM/PO | not captured | standing | page 117 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 117 |
| Respiratory distress | adult | 10 mg | IV/IM/PO | not captured | standing | page 36 |
| Respiratory distress | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 36 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 14 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 14 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 25 mg | IV/IO | not captured | standing | page 54 |
| SVT | adult | 25 mg | IV/IO | not captured | standing | page 54 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | PO | not captured | standing | page 117 |
| Allergic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 117 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 117 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 117 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 27 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 27 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 117 |
| Anaphylaxis | adult | 0.3 mL | IV | not captured | standing | page 117 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 117 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 56 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 66 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 66 |
| Respiratory distress | adult | 0.3 mg | IM | not captured | standing | page 36 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 22 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IM | not captured | standing | page 18 |
| Mild to moderate pain | peds | 2 mcg/kg | IV/IM | not captured | standing | page 18 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3 mg | IV | not captured | standing | page 125 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 14 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 14 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 10 mg/kg | PO | not captured | standing | page 93 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 93 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 500 mcg | NEB | not captured | standing | page 36 |
| Respiratory distress | peds | 500 mcg | NEB | not captured | standing | page 36 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.2 mg/kg | IV | not captured | standing | page 34 |
| Mild to moderate pain | adult | 0.4 mg/kg | IM | not captured | standing | page 34 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV | not captured | standing | page 34 |
| Mild to moderate pain | peds | 0.4 mg/kg | IM | not captured | standing | page 34 |
| Procedural sedation | adult | 1 mg/kg | IV | not captured | standing | page 18 |
| Procedural sedation | peds | 1 mg/kg | IV | not captured | standing | page 18 |
| Procedural sedation | peds | 1 mg/kg | IM | not captured | standing | page 129 |
| RSI induction | adult | 2 mg/kg | IV | not captured | standing | page 22 |
| RSI induction | peds | 2 mg/kg | IV | not captured | standing | page 22 |
| Seizure | adult | 100 mg | IV/IM | not captured | standing | page 40 |
| Seizure | peds | 100 mg | IV/IM | not captured | standing | page 40 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 34 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 34 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 34 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 34 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 30 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 13 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 13 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 1 mg | IV/IO/IM | not captured | standing | page 19 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 19 |
| Seizure | adult | 2 mg | IV/IO/IM | not captured | standing | page 41 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 41 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2 g | IV | not captured | standing | page 36 |
| Respiratory distress | peds | 50 mg/kg | IV | not captured | standing | page 36 |
| Seizure | adult | 4–6 g | IV | not captured | standing | page 40 |
| Wide-complex tachycardia | adult | 1–2 g | IV | not captured | standing | page 65 |
| Wide-complex tachycardia | peds | 25 mg/kg | IV | not captured | standing | page 65 |
| VF / pulseless VT | adult | 1–2 g | IV | not captured | standing | page 66 |
| VF / pulseless VT | peds | 25 mg/kg | IV | not captured | standing | page 66 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IM | not captured | standing | page 117 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 117 |
| Hypotension / shock | adult | 125 mg | IV/IO | not captured | standing | page 33 |
| Respiratory distress | adult | 125 mg | IV/IM | not captured | standing | page 36 |
| Respiratory distress | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 36 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV | not captured | standing | page 54 |
| SVT | adult | 5 mg | IV | not captured | standing | page 54 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | page 129 |
| Agitation | peds | 0.1 mg/kg | IM | not captured | standing | page 129 |
| Post-intubation sedation | adult | 2.5 mg | IV | not captured | standing | page 18 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV | not captured | standing | page 18 |
| Procedural sedation | adult | 2.5 mg | IV/IM | not captured | standing | page 129 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 129 |
| Seizure | adult | 2.5 mg | IV | not captured | standing | page 40 |
| Seizure | adult | 5 mg | IM | not captured | standing | page 40 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 40 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 40 |
| Seizure | peds | 0.2 mg/kg | IN | not captured | standing | page 93 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5–2 mg | IV/IM | not captured | standing | page 24 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | page 24 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 24 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 24 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 400 mcg | SL | not captured | standing | page 60 |
| CHF / pulmonary edema | adult | 1 inch | TD | not captured | standing | page 62 |
| CHF / pulmonary edema | adult | 1200 mcg | SL | not captured | standing | page 62 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 60 |
| Hypotension / shock | adult | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 32 |
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | page 32 |
| Sepsis | adult | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 42 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 16 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 16 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 14 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 14 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV | not captured | standing | page 75 |
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 75 |
Piperacillin-Tazobactam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 3.375 g | IV | not captured | standing | page 42 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 22 |
| RSI induction | peds | 1 mg/kg | IV | not captured | standing | page 22 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mEq | IV/IO | not captured | standing | page 28 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 28 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 28 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 28 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | page 28 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 28 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 52 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 52 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV | not captured | standing | page 22 |
| RSI induction | peds | 1.5 mg/kg | IV | not captured | standing | page 22 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.25 mg | IM | not captured | standing | page 36 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 g | IV | not captured | standing | page 117 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 73 |